A systematic review to evaluate the clinical outcomes in COVID -19 patients on angiotensin converting enzyme inhibitors or angiotensin receptor blockers
Abhinav Grover, Mansi Oberoi
doi: https://doi.org/10.1101/2020.04.29.20085787
Abhinav Grover
1University of California, Irvine School of Medicine, Irvine, California, USA
Mansi Oberoi
2University of South Dakota, Sanford School of Medicine, Sioux Falls, USA
Data Availability
N/A
Posted May 05, 2020.
A systematic review to evaluate the clinical outcomes in COVID -19 patients on angiotensin converting enzyme inhibitors or angiotensin receptor blockers
Abhinav Grover, Mansi Oberoi
medRxiv 2020.04.29.20085787; doi: https://doi.org/10.1101/2020.04.29.20085787
Subject Area
Subject Areas
- Addiction Medicine (325)
- Allergy and Immunology (639)
- Anesthesia (170)
- Cardiovascular Medicine (2432)
- Dermatology (208)
- Emergency Medicine (383)
- Epidemiology (11861)
- Forensic Medicine (10)
- Gastroenterology (706)
- Genetic and Genomic Medicine (3807)
- Geriatric Medicine (353)
- Health Economics (643)
- Health Informatics (2447)
- Health Policy (947)
- Hematology (347)
- HIV/AIDS (800)
- Medical Education (374)
- Medical Ethics (105)
- Nephrology (406)
- Neurology (3562)
- Nursing (201)
- Nutrition (534)
- Oncology (1850)
- Ophthalmology (542)
- Orthopedics (224)
- Otolaryngology (291)
- Pain Medicine (235)
- Palliative Medicine (68)
- Pathology (453)
- Pediatrics (1049)
- Primary Care Research (425)
- Public and Global Health (6230)
- Radiology and Imaging (1309)
- Respiratory Medicine (841)
- Rheumatology (385)
- Sports Medicine (328)
- Surgery (413)
- Toxicology (51)
- Transplantation (174)
- Urology (148)